Kouba E, Cheng L. Neuroendocrine tumors of the urinary bladder according to the 2016 World Health Organization Classification: Molecular and clinical characteristics. Endocr Pathol. 2016; 27:188–99.

Article  PubMed  Google Scholar 

WHO Classification of Tumours Editorial Board. WHO Classification of Tumours: Urinary and Male Genital Tumours. 5th ed, Vol 8, Lyon (France): International Agency for Research on Cancer (IARC), 2022.

Mohanty SK, Lobo A, Cheng L. The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges. Hum Pathol. 2023; 136:123–43.

Article  PubMed  Google Scholar 

Kouba EJ, Cheng L. Understanding the Genetic Landscape of Small Cell Carcinoma of the Urinary Bladder and Implications for Diagnosis, Prognosis, and Treatment: A Review. JAMA Oncol. 2017;3(11):1570–78.

Article  PubMed  Google Scholar 

Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA et al. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol. 2022;33(1):115–54.

Article  CAS  PubMed  Google Scholar 

Gupta S, Thompson RH, Boorjian SA, Thapa P, Hernandez LP, Jimenez RE et al. High-grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma. Pathology. 2015;47(6):533–42.

Article  CAS  PubMed  Google Scholar 

Wang G, Yuan R, Zhou C, Guo C, Villamil C, Hayes M et al. Urinary Large Cell Neuroendocrine Carcinoma: A Clinicopathologic Analysis of 22 Cases. Am J Surg Pathol. 2021;45(10):1399–408.

Article  PubMed  PubMed Central  Google Scholar 

Martignoni G, Eble JN. Carcinoid tumors of the urinary bladder. Immunohistochemical study of 2 cases and review of the literature. Arch Pathol Lab Med. 2003;127: e22–e24.

Article  PubMed  Google Scholar 

Cheng L, Leibovich BC, Cheville JC, et al. Pheochromocytoma of the urinary bladder: Can biologic potential be predicted? Cancer 2000; 88:844–52

Article  CAS  PubMed  Google Scholar 

Shehabeldin AN, Ro JY. Neuroendocrine tumors of genitourinary tract: Recent advances. Ann Diagn Pathol. 2019; 42:48–58.

Article  PubMed  Google Scholar 

Akbulut D, Al-Ahmadie H. Neuroendocrine tumours of the urinary bladder: recent advances. Histopathology. 2026;88(1):108–21.

Article  PubMed  Google Scholar 

Cheng L, Jones TD, McCarthy RP, Eble JN, Wang M, MacLennan GT et al. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol. 2005;166(5):1533–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sved P, Gomez P, Manoharan M, Civantos F, Soloway MS. Small cell carcinoma of the bladder. BJU Int. 2004;94(1):12–7.

Article  PubMed  Google Scholar 

Gaisa NT, Tilki D, Losen I, Dahl E, Stoehr R, Stief CG et al. Insights from a whole cystectomy specimen–association of primary small cell carcinoma of the bladder with transitional cell carcinoma in situ. Hum Pathol. 2008;39(8):1258–62.

Article  CAS  PubMed  Google Scholar 

Gopalan A, Al-Ahmadie H, Chen YB, Sarungbam J, Sirintrapun SJ, Tickoo SK et al. Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series. Histopathology. 2022;81(2):246–54.

Article  PubMed  PubMed Central  Google Scholar 

Beltran H, Hruszkewycz A, Scher HI, Hildesheim J, Isaacs J, Yu EY et al. The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance. Clin Cancer Res. 2019;25(23):6916–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aggarwal R, Huang J, Alumkal JJ, Zhang L, Feng FY, Thomas GV et al. Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study. J Clin Oncol. 2018;36(24):2492–503.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang T, Zhang X, Qian L, Hu C, Li J. Molecular and immune characteristics of neuroendocrine bladder carcinoma - Implications for diagnosis, prognosis, and therapy: A review. Biomol Biomed. 2025;26(5):711–19.

Article  PubMed  PubMed Central  Google Scholar 

Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013;499(7457):214–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tran L, Xiao JF, Agarwal N, Duex JE, Theodorescu D. Advances in bladder cancer biology and therapy. Nat Rev Cancer 2021;21(2):104–21.

Article  CAS  PubMed  Google Scholar 

Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 2017;171(3):540–56.e25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rickman DS, Beltran H, Demichelis F, Rubin MA. Biology and evolution of poorly differentiated neuroendocrine tumors. Nat Med 2017;23(6):1–10.

Article  CAS  PubMed  Google Scholar 

Cancer Genome Atlas Research N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014;507(7492):315–22.

Article  Google Scholar 

Venkatesan S, Rosenthal R, Kanu N, McGranahan N, Bartek J, Quezada SA, et al. Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution. Ann Oncol. 2018;29(3):563–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang MT, Penson A, Desai NB, Socci ND, Shen R, Seshan VE et al. Small-cell carcinomas of the bladder and lung are characterized by a convergent but distinct pathogenesis. Clin Cancer Res. 2018;24(8):1965–73.

Article  CAS  PubMed  Google Scholar 

Shi R, Wang X, Wu Y, Xu B, Zhao T, Trapp C, et al. APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases. Theranostics 2022;12(9):4181–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng X, Zhuge J, Bezerra SM, Faraj SF, Munari E, Fallon JT 3rd et al. High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins. J Hematol Oncol. 2014;7:47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Priemer DS, Wang M, Zhang S, Lopez-Beltran A, Kouba E, Montironi R et al. Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma. Eur Urol Focus. 2018;4(6):880–8.

Article  PubMed  Google Scholar 

Hosen I, Rachakonda PS, Heidenreich B, de Verdier PJ, Ryk C, Steineck G, et al. Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer. Int J Cancer 2015;137(7):1621–9.

Article  CAS  PubMed  Google Scholar 

Bell RJ, Rube HT, Xavier-Magalhaes A, Costa BM, Mancini A, Song JS et al. Understanding TERT promoter mutations: a common path to immortality. Mol Cancer Res 2016;14(4):315–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoffman-Censits J, Choi W, Pal S, Trabulsi E, Kelly WK, Hahn NM, et al. Urothelial cancers with small cell variant histology have confirmed high tumor mutational burden, frequent TP53 and RB mutations, and a unique gene expression profile. Eur Urol Oncol 2021;4(2):297–300.

Article  PubMed